These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 26808165)

  • 21. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical proteomics to identify molecular targets of small compounds.
    Sun B; He QY
    Curr Mol Med; 2013 Aug; 13(7):1175-91. PubMed ID: 23826922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target identification for small bioactive molecules: finding the needle in the haystack.
    Ziegler S; Pries V; Hedberg C; Waldmann H
    Angew Chem Int Ed Engl; 2013 Mar; 52(10):2744-92. PubMed ID: 23418026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances and method development for drug target identification.
    Chan JN; Nislow C; Emili A
    Trends Pharmacol Sci; 2010 Feb; 31(2):82-8. PubMed ID: 20004028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule target identification using photo-affinity chromatography.
    Seo SY; Corson TW
    Methods Enzymol; 2019; 622():347-374. PubMed ID: 31155061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical proteomic strategies for the discovery and development of anticancer drugs.
    Liu Y; Guo M
    Proteomics; 2014 Mar; 14(4-5):399-411. PubMed ID: 24323546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoproteomics and Chemical Probes for Target Discovery.
    Drewes G; Knapp S
    Trends Biotechnol; 2018 Dec; 36(12):1275-1286. PubMed ID: 30017093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tools and methodologies capable of isolating and identifying a target molecule for a bioactive compound.
    Sakamoto S; Hatakeyama M; Ito T; Handa H
    Bioorg Med Chem; 2012 Mar; 20(6):1990-2001. PubMed ID: 22264760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in target identification of bioactive natural products.
    Yoshida M
    Biosci Biotechnol Biochem; 2019 Jan; 83(1):1-9. PubMed ID: 30343630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revealing promiscuous drug-target interactions by chemical proteomics.
    Bantscheff M; Scholten A; Heck AJ
    Drug Discov Today; 2009 Nov; 14(21-22):1021-9. PubMed ID: 19596079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SEC-TID: A Label-Free Method for Small-Molecule Target Identification.
    Salcius M; Bauer AJ; Hao Q; Li S; Tutter A; Raphael J; Jahnke W; Rondeau JM; Bourgier E; Tallarico J; Michaud GA
    J Biomol Screen; 2014 Jul; 19(6):917-27. PubMed ID: 24554445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics accelerating the identification of the target molecule of bioactive small molecules.
    Wierzba K; Muroi M; Osada H
    Curr Opin Chem Biol; 2011 Feb; 15(1):57-65. PubMed ID: 21115389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.